Aeterna Zentaris to Announce Fourth Quarter and Full Year 2012 Financial and Operating Results on March 21, 2013

 Aeterna Zentaris to Announce Fourth Quarter and Full Year 2012 Financial and
                     Operating Results on March 21, 2013

PR Newswire

QUEBEC CITY, March 12, 2013

QUEBEC CITY, March 12, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:
AEZS) (TSX:AEZ) (the "Company") will announce its fourth quarter and
full-year 2012 financial and operating results on Thursday, March 21, 2013,
after market close. The Company will host a conference call the next morning,
Friday, March 22, 2013 at 8:30 a.m. (Eastern Time), to discuss these results.

Participants may access the live webcast via the Company's website at
www.aezsinc.com in the "Newsroom" section, or by telephone using the following
numbers: in Canada, 514-807-9895 or 647-427-7450, outside Canada,
888-231-8191. A replay of the webcast will also be available on the Company's
website for a period of 30 days.

About Aeterna Zentaris

Aeterna Zentaris is an oncology and endocrinology drug development company
currently investigating treatments for various unmet medical needs. The
Company's pipeline encompasses compounds at all stages of development, from
drug discovery through to marketed products. For more information, please
visit www.aezsinc.com.

SOURCE AETERNA ZENTARIS INC.

Contact:

Investor Relations
Ginette Beaudet Vallières
Investor Relations Coordinator
(418) 652-8525 ext. 265
gvallieres@aezsinc.com

Media Relations
Paul Burroughs
Director of Communications
(418) 652-8525 ext. 406
pburroughs@aezsinc.com
 
Press spacebar to pause and continue. Press esc to stop.